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Synaptophysin is a transmembrane glycoprotein of neuroendocrine vesicles. Its content and distribution in subcellular 
fractions from cultured PC12 cells, rat brain and bovine adrenal medulla were determined by a sensitive dot immuno- 
assay. Synaptophysin-containing fractions appeared as monodispersed populations similar to synaptic vesicles in density 
and size distribution. Membranes from synaptic vesicles contained x lOO-times more synaptophysin than chromaffin gra- 
nules. In conclusion, synaptophysin is located almost exclusively in vesicles of brain and PC12 cells which are distinct 
from dense core granules. 
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1. INTRODUCTION 
Synaptophysin is a major integral membrane 
protein of synaptic vesicles of the CNS [ 1,2] which 
occurs as a homooligomer and binds Ca2+ on its 
cytoplasmic domain [3]. The primary structure of 
this protein has recently been derived from cDNA 
clones ([4], see also [5,6]). Synaptophysin seems to 
be intimately involved in neurotransmitter storage 
and neurotransmission, and its developmental ex- 
pression in the CNS coincides with synaptogenesis 
[7,8]. Synaptophysin is widely distributed in 
neoplastic neuroendocrine tissues and cell lines in- 
cluding the cell line PC12 derived from rat 
pheochromocytoma [3,10,12]. Immunoelectron- 
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microscopical studies have suggested that synap- 
tophysin occurs at synapses [1,2] as well as in nor- 
mal [2,1 l] and neoplastic [lo, 121 neuroendocrine 
cells in a distinct type of small (40-80 nm 
diameter) vesicles with an electron-microscopically 
translucent content. However, several aboratories 
[13,14] recently provided evidence for the occur- 
rence of synaptophysin in dense core granule mem- 
branes implying the participation of this 
polypeptide in at least two different secretory vesi- 
cle pathways. Because of this discrepancy between 
direct immunolocalization data and fractionation 
results, we now analyzed the synaptophysin con- 
tent of vesicle fractions derived from rat and 
bovine brain, bovine adrenal medulla as well as 
cultured PC 12 cells by a newly developed dot im- 
munoassay, which can detect 110 fmol synap- 
tophysin. 
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2.1. Ceils 
Abbreviations: BSA, bovine serum albumin: NC, 
nitrocellufose; PAGE, polyacrylamide gel electrophoresis; 
SCV, synaptophysin-containing vesicles 
PC12 cells [15] originally provided by Dr H. Thoenen (Max- 
Planck-Institut fiir Psychiatric, Martinsried) were grown as 
described [3,12]. 
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2.2. Materials 
Nitrocellulose (BA85) and blotting paper were purchased 
from Schleicher & Schiill (Dassel); Percoll, Sephacryl S-500, 
Sephacryl S-1000 and Sepharose 4B from Pharmacia 
(Freiburg); controlled pore glass and tunicamycin from Sigma 
(Miinchen); anti-mouse immunoglobulins coupled to 
horseradish peroxidase from Amersham-Buchler (Braun- 
schweig); and anti-mouse or anti-rabbit IgG coupled to alkaline 
phosphatase frbm Promega (Madison, WI). Monoclonal an- 
tibody SY38 (subclass IgG,) against synaptophysin [2], was 
purified from mouse peritoneal ascites fluid by HPLC. The 
punching apparatus was from Inotech (Wohlen, CH). Murine 
monoclonal antibody SC I against secretogranin I was a kind 
gift from Dr Wieland Huttner (EMBL, Heidelberg). Rabbit an- 
tiserum against bovine dopamine fl-hydroxylase (DBH, EC 
1.14.17.1) was kindly provided by Dr John H. Phillips (Univer- 
sity of Edinburgh Medical School, Edinburgh). 
2.3. Dot immunoassay 
Synaptophysin was determined by an enzyme-linked solid- 
phase immunoassay modified from the method of Becker et al. 
[ 161. Samples (100 or 200 pl, < 10 yg protein) were mixed with 
an equal volume of 0.16 N NaOH in 40% methanol and ab- 
sorbed onto nitrocellulose (NC) sheets in a 96-well dot-blot ap- 
paratus (Schleicher and Schuell). Air-dried sheets were 
incubated in blocking bluffer (buffer A) containing 50 mM 
Tris-Cl (pH 8.0), 150 mM NaCl, 0.5% Triton X-100 and 1% 
milk powder or 5% BSA. The NC was then incubated with an- 
tibody SY38 (about 2.0 &ml) in buffer A containing BSA for 
1 h and washed three times for 5 min with buffer A. The sheet 
was incubated for 4.5 min with horseradish peroxidase coupled 
to goat anti-mouse (IgG) antibody diluted 1: 500 in buffer A 
containing BSA. After three consecutive washes, for 5 min 
each, with buffer A and buffer containing 50 mM Tris-Cl (pH 
8.0) and 150 mM NaCl, the dots carrying the samples were pun- 
ched into a 96-well microwell plate. 150 ~1 per well of 100 mM 
citrate-phosphate buffer (pH 5.0) containing 0.5 mg/ml of o- 
phenylenediamine and 0.01% Hz02 were applied. The reaction 
was stopped by the addition of 50 pl of 25% (w/v) sulfuric acid 
per well. Color development was determined in an ELISA 
reader at 492 nm. All steps were performed at room 
temperature. 
2.4. Preparation of postnuclear supernatants 
Tissue from rat and bovine brain and bovine adrenal medulla 
was washed with ice-cold SEAT buffer [lo mM triethanol- 
amine, 10 mM acetic acid (pH 7.4), 250 mM sucrose, 1 mM 
EDTA] and homogenized in 1.7 ml SEAT buffer per g tissue by 
repeated passage through a 5 ml syringe. The homogenate was 
squeezed once through a 17-gauge needle, diluted with SEAT 
buffer (1 : 1) and rehomogenized by pipetting through the blue 
tip of a Gilson pipette according to Miskimins and Shimizu 
[17]. In some cases, SEAT buffer was replaced by buffer B 
[lo mM Na-Hepes (pH 7.4), 60 mM KCI, 10 mM NaCl, 
160 mM glycine, 0.1 mM EDTA]. The supernatant resulting 
from centrifugation at 550 x g for 5 min was used for further 
experiments. 
PC12 cells were washed from the culture dish, suspended in 
0.5 ml SEAT buffer and triturated 40 x with a fire-narrowed 
Pasteur-pipette tip. In some experiments, subcellular fractions 
of PC12 cells and rat brain were prepared with buffer B. After 
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centrifugation for 5 min at approx. 550 x g, the supernatant 
was removed and the procedure repeated twice. The combined 
supernatants (‘lysates’) contained about 95% of the total synap- 
tophysin as judged by Western and dot immunoblotting. All 
steps were performed at 4°C. In some cases, postnuclear super- 
natants were subjected to hypotonic lysis by adding approx. 
15 vols cold water followed by gentle homogenization in a 
motor-driven Potter-Elvehjem homogenizer (1500 rpm, 10 mM 
Hepes, pH 7.4). After incubation for 30 min on ice, the 
homogenate was centrifuged at 17000 x g for 20 min, and the 
supernatant subjected to centrifugation at 150000 x g for 
90 min. The resulting pellet was homogenized with a Dounce 
homogenizer (‘shock-lysate’) and subjected to Percoll cen- 
trifugation. 
2.5. Purification of membrane fractions 
Synaptic vesicles were isolated according to Huttner et al. 
[18], except that permeation chromatography was omitted. 
Inside-out vesicles derived from human red blood cells and 
chromaffin granule membranes derived from bovine adrenal 
medulla were prepared according to standard procedures 
[19,20]. 
2.6. Electrophoresis and immunoblotting 
SDS-PAGE was performed according to Laemmli [21] using 
10% gels. Blot transfer was done as described by Kyhse- 
Andersen [22], except hat block and wash buffers and primary 
antibodies were the same as for the dot immunoassay. Binding 
of primary antibody was detected by either anti-mouse or anti- 
rabbit antibody (IgG) coupled to alkaline phosphatase. 
2.7. Protein determination 
Protein concentration was determined according to Bradford 
[23]. Relative protein concentrations of inside-out vesicles were 
determined by subjecting identical amounts of Percoll fractions 
to SDS-PAGE and Coomassie blue staining and using band III, 
the major integral membrane protein of inside-out vesicles, as 
a protein reference. The polypeptide band was excised, eluted 
with 1.0 ml of 50% isopropanol, and the eluent quantified 
photometrically at 595 nm. 
3. RESULTS 
3.1. Dot immunoassay 
Based on an immunoassay for the postsynaptic 
glycine receptor [ 161, an immunoassay for synap- 
tophysin of higher specificity and sensitivity than 
previously reported [7,24] was developed. This 
assay was calibrated using purified synaptophysin 
for reference (not shown). The sensitivity of the 
dot immunoassay critically depended on the condi- 
tions of sample application to the NC membrane. 
A solution of 0.08 N NaOH in 20% methanol gave 
the best results, and served as standard application 
medium, unless stated otherwise. The presence of 
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SDS (0.03%) abolished the immunosignal for 
synaptophysin. Triton X-100 (0.03%) reduced the 
signal to approx. 20% of that in detergent-free ap- 
plication buffer. Cholate, octylglucoside, or a mix- 
ture of octylglucoside and deoxycholate gave 
satisfactory results (not shown). Unspecific 
binding of antibody SY38 was assessed either by 
applying similar amounts of rat liver protein to the 
NC or by omitting the antibody. Background 
binding depended on the quality of secondary an- 
tibodies and usually accounted for <5% of total 
binding. Approx. 10 fmol synaptophysin could 
reliably be detected in up to 100 pg (total protein) 
crude brain lysate or 10 ng (total protein) synaptic 
vesicles. A previously described dot immunoassay 
for synaptophysin [24] was approx. lOO-fold less 
sensitive with the SY38 monoclonal antibody Qot 
shown). This difference may be explained by the 
presence of both SDS and Triton X-100 at neutral 
pH in the absence of methanol. Percoll interfered 
with the dot immunoassay at concentrations 
> 0.5%; e.g. the presence of 10% Percoll in the ap- 
plication buffer caused a 4-fold decrease in im- 
munoreactivity (not shown). 
3.2. Synaptophysin content of synaptic vesicle and 
chromaffin granule membranes 
The synaptophysin content of purified synaptic 
vesicle and chromaffin granule membranes was 
compared by immunoblotting (fig. la) and dot im- 
munoassay (fig. 1 b) using monoclonal antibody 
SY38 against synaptophysin. Whereas dopamine 
,&hydroxylase was found solely in chromaffin 
granule membranes (fig.la, lane 5’), synap- 
tophysin was contained primarily in synaptic 
vesicles (fig.la, lane 2’). However, membrane 
preparations of chromaffin granules also contain- 
ed some synaptophysin (fig.la, lane 3 ‘). Synap- 
tophysin immunoreactivity therefore was 
quantified by dot immunoassay. To obtain similar 
dot immunoreactivities for both membrane frac- 
tions, chromaffin granule membranes had to be 
applied in approx. 125-fold excess over synaptic 
vesicles from rat brain on a protein basis (fig.lb). 
Bovine synaptic vesicles showed an immunosignal 
about 25times higher than that of bovine 
chromaffin granule membranes (not shown). This 
difference between rat and bovine may reflect 
variable purities of membrane preparations rather 
than species differences. 
a 
CGM-protein [ ng ] 
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Fig.1. Synaptophysin content of synaptic vesicle and 
chrornaffin granule membranes as determined by immuno- 
blotting (a) and dot immunoassay (b). (a) A postnuclear 
supernatant of rat brain (lanes 1,l I; 30 fig protein), purified 
synaptic vesicle (lanes 2,2’ and 4,4’; 1.5 fig protein) and 
chromaffin granule (lanes 3,3’, 4 fig protein and lanes 5,5 ’ , 
9 pg protein) membranes were subjected to 12.5% SDS-PAGE, 
Lanes: 1-5, Coomassie blue-stained gels; 1 I-5’) corresponding 
immunoreplicas using antibody SY38 (lanes l’-3’) and 
antiserum against DBH (lanes 4’,5’). Arrowhead denotes a 
weakly immunoreactive polypeptide of 40 kDa, typical for 
synaptophysin in adrenal medulla [II]. The positions of 
molecular mass markers are indicated by dots on the left: 
bovine aLbumin, 66 kDa; egg albumin, 45 kDa; glyceraldehyde- 
3-phosphate dehydrogenase, 36 kDa; carbonic anhydrase, 
29 kDa; trypsinogen, 24 kDa; trypsin inhibitor, 20.1 kDa. (b) 
Purified bovine chromaffin granule membranes [CGM (+)I and 
rat synaptic vesicles [SV (m)] were analyzed by dot immuno- 
assay using monoclonal antibody SY38 (for details see section 
2). Note that similar immunosignals are obtained only with a 
lOO-fold protein excess of chromaffin granule membrane 
protein. 
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Fig.2. Percoll gradient analysis of purified vesicles. Purified 
bovine brain synaptic vesicles [SV (o), 250 pg total protein] 
were subjected to Percoll gradient centrifugation; fractions 
(1 ml) were analyzed by dot immunoassay for synaptophysin. 
Maximal immunoreactivity, determined at 492 nm, is found in 
fraction 8, corresponding to a density of 1.030 g/ml.‘Inside-out 
vesicles (A), quantified as described in section 2, sediment in 
fraction 7. Purified bovine chromaffin granules and intact 
human red cells (arrow) form a visible band in fraction 1 of the 
gradient. Fraction 1, bottom; fraction 12, top of the gradient. 
3.3. Percoll gradient centrifugation of subcellular 
fractions of PC12 cells and brain tissue 
The density of SCV was determined by cen- 
trifugation on 20% (w/v) Percoll gradients. Gra- 
dients were calibrated with purified rat brain 
synaptic vesicles, inside-out vesicles of human 
erythrocytes, and chromaffin granules as well as 
intact red cells. Purified synaptic vesicles 
sedimented at a density of 1.030 g/ml similarly to 
inside-out vesicles (fig.2). Synaptic vesicles sub- 
jected to freeze-thawing migrated identically to un- 
frozen synaptic vesicles (not shown). Intact red 
Fig.3. Percoll gradient analysis of synaptophysin-containing 
membrane fractions of rat brain and PC12 cells. Postnuclear 
supernatants of brain (a) and PC12 cells (b) in SEAT buffer, 
before (0) and after (4) hypotonic shock lysis (for details see 
section 2) were subjected to Percoll gradient centrifugation. 
Fractions of 1 ml were analyzed for synaptophysin by dot 
immunoassay. Three immunoreactive peaks were observed. 
Peak I (fraction 12 in a,b) corresponds to synaptophysin, which 
is only partly sedimentable at 150000 x g. Note that 
ultracentrifugation of the osmotically shocked postnuclear 
supernatant reduces the immunosignal in peak I. Peak 11 
(fraction 8 in a and fraction 9 in b) corresponds to densities of 
1.030 and 1.027 g/ml, respectively. These densities are very 
similar to that of purified rat brain synaptic vesicles (see fig.2). 
For immunoblotting (c), equivalent amounts of postnuclear 
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centrifuged on a Percoll gradient in SEAT buffer as described 
in section 2. Aliquots of the postnuclear supernatant of brain 
(BR), PC12 cells (PC), and of the indicated fractions (0.6 ml) 
of the gradient were applied to 10% SDS-PAGE and analyzed 
by Western blotting as described. 
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cells and purified chromaffin granules were found 
as a visible band in the bottom fraction of the gra- 
dient (fig.2). 
When postnuclear supernatants of PC12 cells or 
brain were subjected to centrifugation on Percoll 
density gradients, two major peaks of synap- 
tophysin immunoreactivity were detectable by dot 
assay: peak I near the top of the gradient (fig.3a,b, 
fraction 12), and peak II at a density of 1.030 g/ml 
for brain (fig.3a, fraction 8) and 1.027 g/ml for 
PC12 cells (fig.3b, fraction 9). Osmotic shock and 
homogenization did not affect the positions of im- 
munoreactive peaks of subcellular fractions from 
brain and PC12 cells on Percoll gradients 
(fig.3a,b). Neither the mode of application (i.e. 
sample applied on top or mixed with the Percoll 
prior to centrifugation) nor the method of tissue 
homogenization (i.e. Potter-Elvehjem homoge- 
nizer vs trituration) influenced the position of the 
peaks. When peak II was subjected to recen- 
trifugation, the peak was recovered at the same 
density position as in the first run (not shown). The 
density of the vesicles determined by this method 
therefore reflects intrinsic qualities of the vesicles 
rather than conditions of vesicle preparation. 
However, differences in height of peaks I and III 
most likely reflect variable immunoreactivities in 
the supernatant after ultracentrifugation and in- 
terference by Percoll with immunodetection. 
Synaptophysin molecules from brain and PC12 
cells differ in their apparent molecular mass on 
SDS-PAGE [3]. Thus, SCV from brain and PC12 
cells can be discriminated by Western blotting. 
Postnuclear supernatants from brain and PC12 
cells were mixed and subjected to Percoll gradient 
centrifugation in SEAT buffer. As already ob- 
served by dot immunoassay for synaptophysin, 
SCV derived from PC1 2 cells showed a slightly 
lower density than those derived from brain upon 
sedimentation in SEAT buffer (fig.3c). However, 
these differences were not observed in buffer B 
(not shown). 
3 4. Size-exclusion chromatography of post- 
nuclear supernatants of PC12 cells and rat 
brain 
To analyze the size relationship between purified 
synaptic vesicles and synaptophysin-containing 
subcellular fractions derived from brain and PC12 
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Fig.4. Gel-permeation chromatography of lysates from brain 
and PC12 cells. Equivalent amounts of postnuclear 
supernatants (0) from brain and PC12 cells were mixed and 
subjected to gel filtration. Fractions obtained were analyzed by 
dot immunoassay for synaptophysin (upper panel). Two 
immunoreactive peaks were observed. Note that purified 
synaptic vesicles (A) are confined to peak II only. 
lmmunoreactive fractions were further analyzed by SDS-PAGE 
followed by Coomassie blue staining (second pane1 from top, 
CB) and immunoblotting using antibodies against 
synaptophysin (third panel from top, SY38) and secretogranin 
I (bottom panel, SG I). Lanes: 1, PC12 (PC); 2, rat brain lysate 
(B). Fractions with even numbers (16-34) were analyzed. 
Vertical brackets in panel SG I denote an immunoreactive 
polypeptide doublet of 113/l 15 kDa typical for secretogranin I.
Dots in pane1 SY38 (fractions 20-24) demarcate a polypeptide 
of 38 kDa typical for brain synaptophysin. 
permeation chromatography on columns of 
Sephacryl S-500, S-1000, Sepharose 2B and con- 
trolled pore glass, equilibrated with buffer B. 
Columns of Sephacryl S-500 gave the best 
recovery and resolution and were used exclusively 
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thereafter. When a mixture of postnuclear super- 
natants from PC12 cells and rat brain was sub- 
jected to gel-permeation chromatography, two 
peaks of synaptophysin immunoreactivity were 
observed by dot immunoassay: peak I (fractions 
15-20) was found in the void volume, whereas 
peak II (fractions 20-36) was included in the col- 
umn (fig.4). Purified synaptic vesicles from rat 
brain, prepared according to Huttner et al. [18], 
were found in peak II only. Freeze-thawing of 
these vesicles did not alter their chromatographic 
properties (not shown). Further analysis of these 
two peaks by Western blotting, using monoclonal 
antibody SY38 against synaptophysin, showed that 
synaptophysin-containing fractions from PC12 
cells and rat brain comigrated in both peaks 
(fig.4). Whereas ‘brain’ synaptophysin (38 kDa) 
was predominantly found in peak II,’ ‘PC12’ 
synaptophysin (40 kDa) was found in both peaks I 
and II, indicating that SCV derived from PC12 
cells are at least in part of similar size to that of 
SCV from rat brain. 
Secretogranin I (1131105 kDa), a marker for 
large dense core vesicles in PC12 cells, was iden- 
tified by a specific monoclonal antibody [25] in 
peak I (void volume), indicating that secretory 
granules are excluded from the column (fig.3). 
Furthermore, secretogranin I was detected in frac- 
tions 30-40, known to contain soluble proteins. 
4. DISCUSSION 
Vesicles from neuroendocrine cells and tissues 
can be classified according to their synaptophysin 
content as determined by the combined use of a 
highly sensitive dot immunoassay and separation 
techniques of subcellular particles. (i) Synap- 
tophysin can be recovered from CNS tissue in a 
monodisperse peak fraction, indicating that it is 
located in a distinct type of small vesicles. (ii) 
Synaptophysin is over lOO-fold enriched in mem- 
branes of synaptic vesicles from brain but not of 
chromaffin granules from adrenal medulla. (iii) 
Neuroendocrine neoplastic cells (e.g. PC 12 cells) 
possess synaptophysin-containing vesicles, similar 
in density and size to their normal neuronal 
counterparts. Thus, most of the. synaptophysin 
present in neuroendocrine cells is enriched and 
stored in this distinct form of neurotransmitter 
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vesicle. (iv) Synaptophysin-containing vesicles 
represent a vesicle subpopulation resistant to 
various kinds of preparative treatments such as 
hypotonic shock lysis, homogenization and freeze- 
thawing. 
The present data are based on immunoblotting 
and a newly developed highly sensitive im- 
munoassay for synaptophysin using monoclonal 
antibody SY38 [2], which has been widely 
employed as a broad immunohistochemical probe 
for the identification of normal and neoplastic 
neuroendocrine cells ([9,27]; review [26]). The 
assignment of synaptophysin to vesicle subpopula- 
tions has recently been subject to a controversy. 
Immunoelectron-microscopic data suggest that 
synaptophysin is present in small vesicles with an 
electron-translucent core but not dense core 
vesicles [2,11]. However, the use of fixatives dur- 
ing sample preparation may lead to alterations in 
the structure of vesicles and antigenic epitopes. In 
contrast, Lowe et al. [ 131, based on im- 
munoprecipitation of various vesicle fractions, 
suggested that synaptophysin occurs in addition to 
chromaffin granules. This method, however, is 
limited by high background and does not permit a 
quantitative evaluation of the synaptophysin con- 
tent of these membrane fractions, since even small 
amounts of antigen may lead to a precipitation. 
Therefore, we have studied the distribution of 
synaptophysin in membranes of native vesicle sub- 
populations by immunoassay. Compared to its 
content in small ‘clear’ vesicles, the amount of 
synaptophysin in large dense core vesicles is 
negligibly small. Although small amounts of 
synaptophysin may be found in other membranes, 
we suggest in view of the great differences shown 
here that synaptophysin is specifically sorted into 
the small clear vesicle pathway. The use of detec- 
tion and separation methods reported here may 
lead to an identification of other polypeptides 
associated with synaptophysin-containing vesicles. 
This may help to corroborate further our 
hypothesis that synaptophysin is a specific marker 
of a distinct vesicle pathway. 
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